- Home
- TLSI vs ISTR Comparison
TLSI vs ISTR Comparison
Compare TLSI & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ISTR
- Stock Information
- Founded
- TLSI 2010
- ISTR 2006
- Country
- TLSI United States
- ISTR United States
- Employees
- TLSI N/A
- ISTR N/A
- Industry
- TLSI Medical Specialities
- ISTR Major Banks
- Sector
- TLSI Health Care
- ISTR Finance
- Exchange
- TLSI Nasdaq
- ISTR Nasdaq
- Market Cap
- TLSI 204.0M
- ISTR 189.6M
- IPO Year
- TLSI N/A
- ISTR 2014
- Fundamental
- Price
- TLSI $5.43
- ISTR $19.99
- Analyst Decision
- TLSI Strong Buy
- ISTR Buy
- Analyst Count
- TLSI 5
- ISTR 1
- Target Price
- TLSI $10.90
- ISTR $22.00
- AVG Volume (30 Days)
- TLSI 146.8K
- ISTR 23.1K
- Earning Date
- TLSI 08-13-2025
- ISTR 07-21-2025
- Dividend Yield
- TLSI N/A
- ISTR 2.12%
- EPS Growth
- TLSI N/A
- ISTR 22.25
- EPS
- TLSI N/A
- ISTR 2.19
- Revenue
- TLSI $32,141,000.00
- ISTR $88,885,000.00
- Revenue This Year
- TLSI $55.52
- ISTR $2.04
- Revenue Next Year
- TLSI $54.76
- ISTR $9.79
- P/E Ratio
- TLSI N/A
- ISTR $9.04
- Revenue Growth
- TLSI 46.20
- ISTR 6.35
- 52 Week Low
- TLSI $3.50
- ISTR $14.91
- 52 Week High
- TLSI $6.04
- ISTR $24.81
- Technical
- Relative Strength Index (RSI)
- TLSI 50.01
- ISTR 54.07
- Support Level
- TLSI $5.18
- ISTR $18.58
- Resistance Level
- TLSI $5.65
- ISTR $19.34
- Average True Range (ATR)
- TLSI 0.35
- ISTR 0.50
- MACD
- TLSI -0.02
- ISTR 0.02
- Stochastic Oscillator
- TLSI 49.23
- ISTR 70.22
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.